Andreas Bernkop-Schnürch

Title: The Innovative Contributions of Andreas Bernkop-Schnürch

Introduction

Andreas Bernkop-Schnürch is a notable inventor based in Sankt Veit an der Glan, Austria. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative drug delivery systems. His work focuses on improving the efficacy of treatments for women's health issues.

Latest Patents

Andreas holds a patent for a vaginal delivery system that contains selective estrogen receptor modulators (SERMs). The patent, titled "Vaginal delivery systems containing selective estrogen receptor modulator (SERM) and uses thereof," describes pharmaceutical compositions that include one or more SERMs, such as Lasofoxifene, along with four or more pharmaceutically acceptable excipients. These compositions are designed to form nanodroplets in vaginal fluid, allowing for effective delivery of the SERM to treat or prevent conditions such as vulvovaginal atrophy, dyspareunia, sexual dysfunction, osteoporosis, or breast cancer in female subjects. He has 1 patent to his name.

Career Highlights

Andreas is currently associated with Azure Biotech, Inc., where he continues to innovate in the field of drug delivery systems. His research has the potential to significantly impact women's health by providing more effective treatment options.

Collaborations

He collaborates with esteemed colleagues, including Valerie Ceva and Steven R Goldstein, to advance his research and development efforts.

Conclusion

Andreas Bernkop-Schnürch's work exemplifies the importance of innovation in pharmaceutical sciences, particularly in addressing critical health issues for women. His contributions through patents and collaborations highlight his commitment to improving healthcare solutions.